Citigroup’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,422
Closed -$1.67M 5036
2023
Q2
$1.67M Buy
16,422
+8,415
+105% +$858K ﹤0.01% 1831
2023
Q1
$728K Buy
8,007
+1,259
+19% +$114K ﹤0.01% 2254
2022
Q4
$256K Sell
6,748
-3,677
-35% -$140K ﹤0.01% 2924
2022
Q3
$262K Sell
10,425
-1,469
-12% -$36.9K ﹤0.01% 2959
2022
Q2
$361K Buy
11,894
+3,432
+41% +$104K ﹤0.01% 2829
2022
Q1
$278K Sell
8,462
-3,175
-27% -$104K ﹤0.01% 3217
2021
Q4
$307K Sell
11,637
-15,509
-57% -$409K ﹤0.01% 3353
2021
Q3
$2.73M Buy
27,146
+8,403
+45% +$845K ﹤0.01% 1691
2021
Q2
$2.65M Sell
18,743
-337
-2% -$47.7K ﹤0.01% 1880
2021
Q1
$1.9M Buy
19,080
+3,231
+20% +$322K ﹤0.01% 1963
2020
Q4
$1.96M Sell
15,849
-680
-4% -$84.1K ﹤0.01% 1717
2020
Q3
$1.61M Sell
16,529
-8,915
-35% -$868K ﹤0.01% 1633
2020
Q2
$3.97M Buy
25,444
+1,991
+8% +$311K ﹤0.01% 1203
2020
Q1
$3.39M Buy
23,453
+3,701
+19% +$534K ﹤0.01% 1127
2019
Q4
$4.04M Sell
19,752
-580
-3% -$119K ﹤0.01% 1225
2019
Q3
$1.63M Buy
20,332
+4,478
+28% +$360K ﹤0.01% 1759
2019
Q2
$1.5M Buy
15,854
+5,085
+47% +$480K ﹤0.01% 1849
2019
Q1
$921K Buy
10,769
+2,141
+25% +$183K ﹤0.01% 2041
2018
Q4
$484K Buy
8,628
+797
+10% +$44.7K ﹤0.01% 2522
2018
Q3
$640K Buy
7,831
+6,508
+492% +$532K ﹤0.01% 2338
2018
Q2
$46K Sell
1,323
-1,227
-48% -$42.7K ﹤0.01% 3931
2018
Q1
$52K Buy
2,550
+1,329
+109% +$27.1K ﹤0.01% 3742
2017
Q4
$35K Buy
1,221
+181
+17% +$5.19K ﹤0.01% 3989
2017
Q3
$32K Buy
1,040
+949
+1,043% +$29.2K ﹤0.01% 3838
2017
Q2
$3K Sell
91
-668
-88% -$22K ﹤0.01% 4478
2017
Q1
$17K Sell
759
-4,962
-87% -$111K ﹤0.01% 4132
2016
Q4
$125K Buy
5,721
+5,255
+1,128% +$115K ﹤0.01% 3821
2016
Q3
$12K Sell
466
-106
-19% -$2.73K ﹤0.01% 4394
2016
Q2
$11K Buy
+572
New +$11K ﹤0.01% 4485